QTL |
GWAS Catalog Study |
Disease Trait |
Study Size |
Risk Allele |
Risk Allele Frequency |
P Value |
P Value MLOG |
Peak Marker |
Reported Odds Ratio or Beta-coefficient |
Ontology Accession |
PubMed |
GWAS693904_H |
GCST90264174 |
Intelligence |
223,731 British ancestry individuals |
? |
NR |
1E-14 |
14 |
rs34592089 |
N/A |
intelligence (EFO:0004337)
|
PMID:36378351 |
GWAS699266_H |
GCST90271813 |
Ventromedial occipital thickness (unadjusted for global measures) |
32,488 European ancestry individuals |
? |
NR |
3E-12 |
11.523 |
rs34592089 |
0.1069 |
cortical thickness (EFO:0004840)
|
PMID:36893272 |
GWAS739355_H |
GCST90297779 |
Idiopathic knee osteoarthritis |
90,888 European ancestry cases, 263,673 European ancestry controls |
A |
0.06 |
7E-12 |
11.155 |
rs34592089 |
1.08 |
osteoarthritis, knee (EFO:0004616)
|
PMID:37247657 |
GWAS780554_H |
GCST003044 |
Crohn's disease |
5,956 European ancestry cases, 14,927 European ancestry controls |
? |
NR |
1E-15 |
15 |
rs34592089 |
N/A |
Crohn's disease (EFO:0000384)
|
PMID:26192919 |
GWAS801752_H |
GCST009518 |
Brain region volumes |
19,629 British ancestry individuals |
? |
NR |
7E-10 |
9.155 |
rs34592089 |
N/A |
brain volume measurement (EFO:0006930)
|
PMID:31676860 |
GWAS803375_H |
GCST009518 |
Brain region volumes |
19,629 British ancestry individuals |
? |
NR |
3E-8 |
7.523 |
rs34592089 |
N/A |
brain volume measurement (EFO:0006930)
|
PMID:31676860 |
GWAS804646_H |
GCST009518 |
Brain region volumes |
19,629 British ancestry individuals |
? |
NR |
3E-13 |
12.523 |
rs34592089 |
N/A |
brain volume measurement (EFO:0006930)
|
PMID:31676860 |
GWAS810361_H |
GCST005316 |
Intelligence (MTAG) |
120,934 British ancestry individuals, 127,548 individuals |
A |
NR |
1E-12 |
12 |
rs34592089 |
0.046348527 |
intelligence (EFO:0004337)
|
PMID:29326435 |
GWAS814969_H |
GCST90019497 |
Aspartate aminotransferase levels |
341,246 European ancestry individuals, 5,982 African ancestry individuals, 7,313 South Asian ancestry individuals |
A |
NR |
3E-27 |
26.523 |
rs34592089 |
0.0545 |
aspartate aminotransferase measurement (EFO:0004736)
|
PMID:33462484 |
GWAS821650_H |
GCST90019493 |
Serum albumin levels |
313,032 European ancestry individuals, 5,573 African ancestry individuals, 6,687 South Asian ancestry individuals |
A |
NR |
2E-24 |
23.699 |
rs34592089 |
0.0535 |
serum albumin measurement (EFO:0004535)
|
PMID:33462484 |
GWAS829821_H |
GCST90019500 |
Calcium levels |
313,387 European ancestry individuals, 5,576 African ancestry individuals, 6,696 South Asian ancestry individuals |
A |
NR |
6E-30 |
29.222 |
rs34592089 |
0.0598 |
calcium measurement (EFO:0004838)
|
PMID:33462484 |
GWAS868285_H |
GCST006269 |
General cognitive ability |
up to 300,486 European ancestry individuals |
A |
NR |
3E-16 |
15.523 |
rs34592089 |
8.166 |
intelligence (EFO:0004337)
|
PMID:29844566 |
GWAS896873_H |
GCST90019495 |
Apolipoprotein A1 levels |
311,601 European ancestry individuals, 5,550 African ancestry individuals, 6,682 South Asian ancestry individuals |
A |
NR |
2E-41 |
40.699 |
rs34592089 |
0.0709 |
apolipoprotein A 1 measurement (EFO:0004614)
|
PMID:33462484 |
GWAS921592_H |
GCST009685 |
Hypertension |
30,822 British ancestry normal blood pressure individuals, 25,242 British ancestry elevated blood pressure individuals, 50,461 British ancestry stage 1 hypertension individuals, 75,286 British ancestry stage 2 hypertension individuals, 3,754 British ancestry hypertension crisis individuals |
? |
NR |
1E-9 |
9 |
rs34592089 |
0.07719143 |
hypertension (EFO:0000537)
|
PMID:31879980 |
GWAS933265_H |
GCST90019501 |
Total cholesterol levels |
342,508 European ancestry individuals, 6,014 African ancestry individuals, 7,336 South Asian ancestry individuals |
A |
NR |
2E-23 |
22.699 |
rs34592089 |
0.0502 |
total cholesterol measurement (EFO:0004574)
|
PMID:33462484 |
GWAS948765_H |
GCST90428119 |
Body mass index |
342,566 European ancestry individuals |
A |
NR |
6E-21 |
20.222 |
rs34592089 |
0.0467757 |
body mass index (EFO:0004340)
|
PMID:38538606 |
GWAS954160_H |
GCST90428121 |
Whole body fat mass (UKB data field 23100) |
337,196 European ancestry individuals |
A |
NR |
1E-13 |
13 |
rs34592089 |
0.036439 |
fat body mass (EFO:0005409)
|
PMID:38538606 |
GWAS956965_H |
GCST90019512 |
Low density lipoprotein cholesterol levels |
341,875 European ancestry individuals, 6,003 African ancestry individuals, 7,319 South Asian ancestry individuals |
A |
NR |
4E-9 |
8.398 |
rs34592089 |
0.0295 |
low density lipoprotein cholesterol measurement (EFO:0004611)
|
PMID:33462484 |
GWAS966329_H |
GCST90019510 |
High density lipoprotein cholesterol levels |
313,372 European ancestry individuals, 5,573 African ancestry individuals, 6,689 South Asian ancestry individuals |
A |
NR |
3E-51 |
50.523 |
rs34592089 |
0.0791 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:33462484 |
GWAS988527_H |
GCST90019524 |
Urate levels |
342,087 European ancestry individuals, 6,011 African ancestry individuals, 7,328 South Asian ancestry individuals |
A |
NR |
1E-10 |
10 |
rs34592089 |
0.0325 |
urate measurement (EFO:0004531)
|
PMID:33462484 |
GWAS991318_H |
GCST90134330 |
Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy) |
20,183 European ancestry ADHD cases, 18,381 European ancestry ASD cases, up to 63,160 European ancestry controls, 269,867 European ancestry individuals with intelligence measurements |
? |
NR |
2E-18 |
17.699 |
rs34592089 |
N/A |
attention deficit hyperactivity disorder (EFO:0003888) autism spectrum disorder (EFO:0003756) intelligence (EFO:0004337)
|
PMID:35764056 |
None Available |
GCST90448240 |
Fluid intelligence |
337,199 European ancestry individuals |
? |
NR |
5E-10 |
9.302 |
rs34592089 |
0.1176 |
intelligence (EFO:0004337)
|
PMID:38434247 |